Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Durez, Patrick*" or (type exact bookEditor and editor="Durez, Patrick*")

Add to list
- Journal Article
- A1
- open access
A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration : the Be-Raise study

Sophie De Mits (UGent) , Jan Lenaerts, Bert Vander Cruyssen, Herman Mielants (UGent) , René Westhovens, Patrick Durez and Dirk Elewaut (UGent)

(2016) PLOS ONE. 11(11).
Add to list
- Journal Article
- A1
- open access
Heterogeneity of synovial molecular patterns in patients with arthritis

Bernard R Lauwerys, Daniel Hernández-Lobato, Pierre Gramme, Julie Ducreux, Adrien Dessy, Isabelle Focant, Jérôme Ambroise, Bertrand Bearzatto, Adrien Nzeusseu Toukap, Benoît J Van den Eynde, et al.

(2015) PLOS ONE. 10(4).
Add to list
Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry

Filip De Keyser (UGent) , Ilse Hoffman, Patrick Durez, Marie-Joëlle Kaiser and R Westhovens

(2014) JOURNAL OF RHEUMATOLOGY. 41(9). p.1761-1765
Add to list
Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort study

Filip De Keyser (UGent) , Joris De Kock, Hermine Leroi, Patrick Durez and René Westhovens

(2014) JOURNAL OF RHEUMATOLOGY. 41(7). p.1276-1281
Add to list
- Journal Article
- A1
- open access
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial

René Westhovens, Filip De Keyser (UGent) , Dmytro Rekalov, Evgeny L Nasonov, Johan Beetens, Annegret Van der Aa, Piet Wigerinck, Florence Namour, Frédéric Vanhoutte and Patrick Durez

(2013) ANNALS OF THE RHEUMATIC DISEASES. 72(5). p.741-744
Add to list
- Conference Paper
- C3
Three-year follow-up of rituximab in rheumatoid arthritis: results from the Belgian MIRA (MabThera in Rheumatoid Arthritis) registry

Filip De Keyser (UGent) , Patrick Durez, René Westhovens, Marie-Joëlle Kaiser and Ilse Hoffman

(2012) ARTHRITIS AND RHEUMATISM. 64(10, suppl.). p.S560-S560
Add to list
- Conference Paper
- C3
A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: the Be-Raise study

Jan Lenaerts, Bert Vander Cruyssen, Herman Mielants (UGent) , Rene Westhovens, Patrick Durez and Dirk Elewaut (UGent)

(2011) ARTHRITIS AND RHEUMATISM. 63(10, suppl.). p.S163-S164
Add to list
- Conference Paper
- C3
A twelve-week exploratory phase II trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate

Rene Westhovens, Filip De Keyser (UGent) , Dmitro Rekalov, Evgeny L Nasonov, Johan Beetens, Annegret Van der Aa, Piet Wigerinck, Florence Namour, Frederic Vanhoutte and Patrick Durez

(2011) ARTHRITIS AND RHEUMATISM. 63(10, suppl.). p.S874-S875
Add to list
- Conference Paper
- C3
Feasibility of a molecular diagnosis of arthritis based on the identification of specific transcriptomic profiles in knee synovial biopsies

Isabelle Focant, Daniel Hernandez-Lobato, Julie Ducreux, Patrick Durez, Adrien Nzeusseu Toukap, Dirk Elewaut (UGent) , Frédéric A Houssiau, Pierre Dupont and Bernard Lauwerys

(2011) ARTHRITIS AND RHEUMATISM. 63(10, suppl.). p.S751-S751
Add to list
- Journal Article
- A1
- open access
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

Bert Vander Cruyssen (UGent) , Patrick Durez, Rene Westhovens, Marie-Joelle Kaiser, Ilse Hoffman and Filip De Keyser (UGent)

(2010) ARTHRITIS RESEARCH & THERAPY. 12(5).

Academic Bibliography

A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration : the Be-Raise study

Heterogeneity of synovial molecular patterns in patients with arthritis

Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry

Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort study

Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial

Three-year follow-up of rituximab in rheumatoid arthritis: results from the Belgian MIRA (MabThera in Rheumatoid Arthritis) registry

A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: the Be-Raise study

A twelve-week exploratory phase II trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate

Feasibility of a molecular diagnosis of arthritis based on the identification of specific transcriptomic profiles in knee synovial biopsies

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

Contents

Support

Contact